[Premature membrane rupture: effect of intracervical PGE2 gel administration on plasma oxytocin, PGFM and PGEM levels in mother and child].
Premature rupture (= PR) of the amnion is a serious complication even for the mature child if it occurs earlier than 24 hours before birth. To keep the interval as short as possible, the authors induce labour from week 35/0 in case of PR, provided the Bishop score is greater than 7. If the bishop score is lower, they conduct intracervical priming of the cervix with 0.4 mg PGE2 gel before induction of labour. This has proved clinically superior to intravenous procedures. In the study presented here, the authors attempted to find out whether intracervical administration of PGE2 gel would result in changes in the maternal and foetal plasma concentrations of oxytocin, PGFM, or PGEM when comparing conditions in case of ruptured amnion with those if the amnion remained intact. If the amnion is intact and the cervix immature (less than 2 cm), intracervical administration of 0.4 mg PGE2 gel produces a significant OT increase within 30 minutes. From a cervical width of 2 cm onwards, the OT levels are already primarily enhanced and will hardly change even after PGE2 gel administration. Similar conditions obtain in PR. PGFM plasma levels will rise only slightly within an hour after intracervical PGE2 gel administration, independent of whether there has been a rupture or not, or whether the cervix is dilated less than 2 cm or 2 cm and more.(ABSTRACT TRUNCATED AT 250 WORDS)
D000287:Administration, Topical; D002584:Cervix Uteri / Q000187:drug effects*; D015237:Dinoprost / Q000031:analogs & derivatives*; D015232:Dinoprostone / Q000031:analogs & derivatives; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D010121:Oxytocin / Q000097:blood*; D011247:Pregnancy; D011458:Prostaglandins E / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use*; D011460:Prostaglandins F / Q000097:blood*
D011458:Prostaglandins E; D011460:Prostaglandins F; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; C025087:15-keto-13,14-dihydroprostaglandin E2; D010121:Oxytocin; D015237:Dinoprost; D015232:Dinoprostone
Vorzeitiger Blasensprung: Einfluss von intrazervikaler PGE2-Gel-Gabe auf Oxytocin-, PGFM- und PGEM-Plasma-Konzentrationen bei Mutter und Kind.